2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on R/R Indolent Lymphoma: Is Anti-CD19 CAR-T Axi-cel a Promising Therapeutic Approach for Patients With R/R iNHL?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Jakub Svoboda
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Jakub Svoboda
118 views
August 6, 2020
Comments 0
Login to view comments.
Click here to Login
Hematologic Oncology